Figure 1From: Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study Total overall survival (OS) of patients with ABC in the 2 nd + line of treatment, who received a modified biweekly regimen of BEV and PAC.Back to article page
